11. Beyond PD-L1: novel predictive biomarkers for adjuvant immunotherapy in renal cell and urothelial carcinoma. Issue 3 (2022) Authors: Brown, Jason R; Rajkumar, Aarthi; Garcia, Jorge A Journal: Immuno-oncology insights Issue: Volume 3:Issue 3(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
12. Biomanufacturing I-O therapeutics in the 21st century. Issue 6 (2021) Authors: ZARBIS-PAPASTOITSIS, GREGORY Journal: Immuno-oncology insights Issue: Volume 2:Issue 6(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
13. Bispecifics come of age: how preclinical tools are helping drive translation to the clinic. Issue 8 (2022) Authors: McGuigan, Roisin; Morrow, Michelle Journal: Immuno-oncology insights Issue: Volume 3:Issue 8(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
14. Cancer immunotherapy & clinical trial design: issues & practice. Issue 3 (2022) Authors: Dancey, Janet E Journal: Immuno-oncology insights Issue: Volume 3:Issue 3(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
15. Cancer Immunotherapy 2020: Opportunities and Challenges on the Road Ahead. Issue 1 (2020) Authors: Arnaldez, Fernanda I; Wigginton, Jon M Journal: Immuno-oncology insights Issue: Volume 1:Issue 1(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
16. Cancer in 4D: the importance of spatial and temporal heterogeneity through breast cancer molecular cartography. Issue 5 (2021) Authors: Martinez, Constanza Journal: Immuno-oncology insights Issue: Volume 2:Issue 5(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
17. Cell-based therapies for cancer treatment: leveraging advanced flow cytometry for greater clinical insight. Issue 5 (2021) Authors: Fan, Rong; Laskowski, Tamara J; Senutovitch, Nina Journal: Immuno-oncology insights Issue: Volume 2:Issue 5(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
18. Clinical development strategy of immunotherapy combination. Issue 1 (2020) Authors: Enokida, Tomohiro; Carr, Caitlin; Bhardwaj, Nina Journal: Immuno-oncology insights Issue: Volume 1:Issue 1(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
19. Clinical development strategy. Issue 1 (2020) Authors: WIGGINTON, JON Journal: Immuno-oncology insights Issue: Volume 1:Issue 1(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
20. Clinical success of checkpoint inhibitors: what's next for combination therapy in I-O. Issue 1 (2020) Journal: Immuno-oncology insights Issue: Volume 1:Issue 1(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗